07 March, 2009

Alnylam and Cubist Form Strategic Collaboration to Develop and ... - Genetic Engineering News

Cubist Pharmaceuticals, Inc., ( Nasdaq: CBST ), a leading acute care biopharmaceutical company, and Alnylam Pharmaceuticals, Inc. ( Nasdaq: ALNY), a leading RNAi therapeutics company, ann...

Read More...